Roundtable Discussion: How to Create a Reference Document to Facilitate Smooth Approval of mRNA Therapeutics in Compliance with Industry Regulations
Time: 10:00 am
day: Conference Day Two
Details:
- Delving into how to give evidence of a state of control and maintain regulatory compliance for your mRNA analytical techniques
- Unveiling strategies to incorporate innovative mRNA analytical technologies in alignment with GMP guidelines
- Understanding the process of standardizing mRNA analytical techniques to conform to CQAs and CPIs, thereby enabling efficient and expeditious approval
